Every material Form 8-K HERBALIFE LTD. has filed with the SEC since August 05, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Herbalife reported third-quarter 2026 net sales of $1.35 billion, up 6.0% from a year earlier, and diluted EPS of $0.55 versus $0.42. The company raised its full-year 2026 net sales guidance and maintained its reported adjusted EBITDA guidance, while announcing a new $250 million share repurchase program and a leadership change, with John DeSimone named interim CEO and Scott Schaefer named CFO, both effective November 1, 2026.
Q3 net sales of $1.35 billion, up 6.0% year over year (7.6% at constant currency); net income attributable to Herbalife of $58.8 million vs. $43.2 million a year earlier
Diluted EPS of $0.55 vs. $0.42; adjusted diluted EPS of $0.64 vs. $0.50
Full-year 2026 net sales guidance increased on reported and constant currency bases; adjusted EBITDA guidance maintained on a reported basis
Board authorized a share repurchase program of up to $250 million over three years; no shares were repurchased in Q3; John DeSimone named interim CEO
Herbalife announced that Chief Executive Officer Stephan Gratziani will transition from his role effective October 31, 2026. The filing does not name a successor or state the reasons for the change.
Stephan Gratziani will transition from his role as Chief Executive Officer.
The transition is effective October 31, 2026.
The company announced the change on August 31, 2026.
The filing does not name a successor or describe the reason for the change.
Herbalife reported second-quarter 2026 net sales of $1.3 billion, up 5.4% year over year and at the top of its guidance range, but posted a net loss attributable to Herbalife of $(26.3) million due mainly to a $94.6 million loss on debt extinguishment. The company narrowed its full-year adjusted EBITDA guidance to $670 million to $690 million, citing foreign exchange headwinds, and said CFO John DeSimone will retire at year-end with Scott Schaefer succeeding him.
Q2 net sales of $1.3 billion, up 5.4% year over year; adjusted EBITDA of $166.6 million.
Net loss attributable to Herbalife of $(26.3) million, compared with net income of $49.3 million in Q2 2025; diluted loss per share of $(0.25).
Full-year 2026 adjusted EBITDA guidance narrowed to $670 million to $690 million from $675 million to $705 million, primarily reflecting FX headwinds.
CFO John DeSimone retires December 31, 2026; Scott Schaefer, current SVP Finance and Transformation, becomes CFO effective January 1, 2027.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every HERBALIFE LTD. filing is on SEC EDGAR ↗. 8-K briefs of other companies →